Research Article

Change in Serum Uric Acid is a Useful Predictor of All-Cause Mortality among Community-Dwelling Persons

Table 3

Hazard ratios and 95% CIs for all-cause mortality according to %dSUA quintiles by subanalysis.

Baseline characteristicsN%dSUA quintiles for trend
Hazard ratio (95% CI)
Quintile 1Quintiles 2–4Quintile 5
<−1.88% (year)−1.87 to 2.50% (year)≥2.51% (year)

Age
 <65 years6465.82 (2.07–16.4)1.000.75 (0.17–3.38)0.003
 ≥65 years6552.77 (1.21–6.37)1.000.98 (0.43–2.22)0.043
Body mass index
 <22.0 kg/m24967.59 (2.13–27.0)1.002.93 (1.05–8.18)0.005
 ≥22.0 kg/m28053.08 (1.46–6.48)1.000.42 (0.13–1.42)0.002
Medication#
 Absence8184.32 (1.98–9.44)1.000.33 (0.08–1.39)0.001
 Presence4832.85 (1.03–7.90)1.001.59 (0.62–4.04)0.334
Chronic kidney disease
 eGFR <60 mL/min/1.73 m2951.80 (0.22–14.8)1.0020.0 (1.09–369)0.112
 eGFR ≥60 mL/min/1.73 m21,2064.07 (2.06–8.06)1.000.73 (0.32–1.66)<0.001
Hyperuricemia
 SUA <6.0 for men or <5.0 for women8064.67 (1.94–11.2)1.000.91 (0.41–2.03)0.001
 SUA ≥6.0 for men or ≥5.0 for women4953.39 (1.26–9.16)1.003.08 (0.62–15.2)0.042

%dSUA, percentage change in serum uric acid; CI, confidence interval. #Antihypertensive medication, antidyslipidemic medication, antidiabetic medication. Multivariable-adjusted for gender, age, body mass index, smoking habits, drinking habits, history of cardiovascular disease, hypertension, hypertriglyceridemia, low HDL-cholesterolemia, hyper LDL-cholesterolemia, diabetes, chronic kidney disease, and hyperuricemia. Bolded numbers indicate significance ().